Idelalisib monotherapy and durable responses in patients with relapsed or refractory marginal zone lymphoma (MZL)

被引:0
|
作者
Martin, P. [1 ]
Armas, A. [2 ]
Gopal, A. [3 ]
Gyan, E. [4 ]
Wagner-Johnston, N. [5 ]
Walewski, J. [6 ]
Abella, S. [7 ]
Ye, W. [7 ]
Philip, B. [7 ]
Sorenson, B. [7 ]
de Vos, S. [8 ]
机构
[1] Weill Cornell Med Coll, Div Hematol Oncol, New York, NY USA
[2] Calaway Young Canc Ctr, Glenwood Springs, CO USA
[3] Univ Washington, Div Med Oncol, Seattle, WA 98195 USA
[4] Ctr Hosp Univ, Serv Hematol & Therapie Cellulaire, Tours, France
[5] Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA
[6] Maria Sklodowska Curie Mem Canc Ctr & Inst Oncol, Dept Lymphoproliferat Dis, Warsaw, Poland
[7] Gilead Sci Inc, 353 Lakeside Dr, Foster City, CA 94404 USA
[8] Univ Calif Los Angeles, David Geffen Sch Med, Div Hematol Oncol, Los Angeles, CA 90095 USA
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
241
引用
下载
收藏
页码:100 / 100
页数:1
相关论文
共 50 条
  • [21] Efficacy of Copanlisib Monotherapy in Patients with Relapsed or Refractory Marginal Zone Lymphoma: Subset Analysis from the CHRONOS-1 Trial
    Dreyling, Martin
    Panayiotidis, Panayiotis
    Egyed, Miklos
    Follows, George
    Mollica, Luigina
    Nagler, Arnon
    Ozcan, Muhit
    Santoro, Armando
    Ishida, Tatiane
    Lu, Cindy
    Hiemeyer, Florian
    Garcia-Vargas, Jose
    Childs, Barrett H.
    Zinzani, Pier Luigi
    BLOOD, 2017, 130
  • [22] Efficacy of Copanlisib Monotherapy in Patients With Relapsed or Refractory Marginal Zone Lymphoma: Subset Analysis From the CHRONOS-1 Trial
    Martin, Peter
    CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2018, 16 (04) : 10 - 11
  • [23] Management of relapsed/refractory marginal zone lymphoma: focus on ibrutinib
    Denlinger, Nathan M.
    Epperla, Narendranath
    William, Basem M.
    CANCER MANAGEMENT AND RESEARCH, 2018, 10 : 615 - 624
  • [24] Results of upfront therapy for marginal zone lymphoma (MZL).
    Cabanillas, Fernando
    Ortega, Jose Luis
    Rivera-Rodriguez, Noridza
    Rodriguez, Blanca
    Pardo, Wandaly Ibis
    Pavia, Orestes Antonio
    Bruno, Margarita
    Santiago, Karen J.
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [25] IDELALISIB IS ACTIVE IN RELAPSED AND REFRACTORY INDOLENT LYMPHOMA
    不详
    CANCER DISCOVERY, 2014, 4 (03) : 271 - 271
  • [26] TREATMENT PATTERNS AND HEALTH CARE COSTS IN PATIENTS WITH FOLLICULAR LYMPHOMA (FL) OR MARGINAL ZONE LYMPHOMA (MZL)TREATMENT PATTERNS AND HEALTH CARE COSTS IN PATIENTS WITH FOLLICULAR LYMPHOMA (FL) OR MARGINAL ZONE LYMPHOMA (MZL)
    Clancy, Z.
    Bell, E.
    Chastek, B.
    Bunner, S.
    Copher, R.
    Arekapudi, S.
    VALUE IN HEALTH, 2020, 23 : S41 - S41
  • [27] Impact of hematopoietic stem cell transplantation in patients with relapsed or refractory marginal zone lymphoma
    Satoshi Yamasaki
    Dai Chihara
    Isao Yoshida
    Kyuhei Kohda
    Masashi Sawa
    Hiroatsu Ago
    Kazuto Togitani
    Yuju Ohno
    Junji Tanaka
    Takahiro Fukuda
    Yoshiko Atsuta
    Junji Suzumiya
    Ritsuro Suzuki
    Annals of Hematology, 2019, 98 : 1521 - 1523
  • [28] Impact of hematopoietic stem cell transplantation in patients with relapsed or refractory marginal zone lymphoma
    Yamasaki, Satoshi
    Chihara, Dai
    Yoshida, Isao
    Kohda, Kyuhei
    Sawa, Masashi
    Ago, Hiroatsu
    Togitani, Kazuto
    Ohno, Yuju
    Tanaka, Junji
    Fukuda, Takahiro
    Atsuta, Yoshiko
    Suzumiya, Junji
    Suzuki, Ritsuro
    ANNALS OF HEMATOLOGY, 2019, 98 (06) : 1521 - 1523
  • [29] Impact of Hematopoietic Stem Cell Transplantation in Patients with Relapsed or Refractory Marginal Zone Lymphoma
    Yamasaki, Satoshi
    Chihara, Dai
    Yoshida, Isao
    Kohda, Kyuhei
    Sawa, Masashi
    Ago, Hiroatsu
    Togitani, Kazuto
    Ohno, Yuju
    Tanaka, Junji
    Fukuda, Takahiro
    Atsuta, Yoshiko
    Suzumiya, Junji
    Suzuki, Ritsuro
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2019, 25 (03)
  • [30] Lenalidomide Oral Monotherapy Produces Durable Responses in Relapsed or Refractory Indolent Non-Hodgkin's Lymphoma
    Witzig, Thomas E.
    Wiernik, Peter H.
    Moore, Timothy
    Reeder, Craig
    Cole, Craig
    Justice, Glen
    Kaplan, Henry
    Voralia, Michael
    Pietronigro, Dennis
    Takeshita, Kenichi
    Ervin-Haynes, Annette
    Zeldis, Jerome B.
    Vose, Julie M.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (32) : 5404 - 5409